- Home
- IPHA vs CBNA Comparison
IPHA vs CBNA Comparison
Compare IPHA & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- CBNA
- Stock Information
- Founded
- IPHA 1999
- CBNA 2006
- Country
- IPHA France
- CBNA United States
- Employees
- IPHA N/A
- CBNA N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- CBNA
- Sector
- IPHA Health Care
- CBNA
- Exchange
- IPHA Nasdaq
- CBNA NYSE
- Market Cap
- IPHA 160.1M
- CBNA 159.8M
- IPO Year
- IPHA 2019
- CBNA 2024
- Fundamental
- Price
- IPHA $2.18
- CBNA $26.76
- Analyst Decision
- IPHA Strong Buy
- CBNA Buy
- Analyst Count
- IPHA 1
- CBNA 3
- Target Price
- IPHA $11.00
- CBNA $29.67
- AVG Volume (30 Days)
- IPHA 28.8K
- CBNA 23.6K
- Earning Date
- IPHA 03-27-2025
- CBNA 04-28-2025
- Dividend Yield
- IPHA N/A
- CBNA N/A
- EPS Growth
- IPHA N/A
- CBNA 60.12
- EPS
- IPHA N/A
- CBNA 4.10
- Revenue
- IPHA $20,831,349.00
- CBNA $57,087,000.00
- Revenue This Year
- IPHA $209.83
- CBNA N/A
- Revenue Next Year
- IPHA $83.15
- CBNA $17.43
- P/E Ratio
- IPHA N/A
- CBNA $6.58
- Revenue Growth
- IPHA N/A
- CBNA 62.88
- 52 Week Low
- IPHA $1.29
- CBNA $20.01
- 52 Week High
- IPHA $3.51
- CBNA $27.97
- Technical
- Relative Strength Index (RSI)
- IPHA 53.46
- CBNA N/A
- Support Level
- IPHA $2.06
- CBNA N/A
- Resistance Level
- IPHA $2.24
- CBNA N/A
- Average True Range (ATR)
- IPHA 0.09
- CBNA 0.00
- MACD
- IPHA -0.01
- CBNA 0.00
- Stochastic Oscillator
- IPHA 53.33
- CBNA 0.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About CBNA CHAIN BRIDGE BANCORP INC
Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.